The Neurodiagnostics Report: Brain Imaging, Biomarkers and NeuroInformatics : Market Research Report

The Neurodiagnostics Report: Brain Imaging, Biomarkers and NeuroInformatics

Published: Feb. 13, 2009 - 103 Pages

1 Neurodiagnostic Markets: Sector Overview; Neurodiagnostics Industry Taxonomy; FDA Approval and Reimbursement of Diagnostics; Market Opportunities in Neurology and Psychiatry; Number of People impacted by Neurological and Psychiatric Disorders, WW and US; Neurology Markets and Emerging Diagnostics; Diagnostic Tests for Alzheimer’s on the horizon; Psychiatry Markets and Emerging Diagnostics
2 Neuroimaging: Medical Divisions of Fortune 500 Companies; Computed Tomography (CT); Nuclear Medicine Imaging (PET, SPECT); Electro-encephalography (EEG); Neurofeedback and Brain Computer Interfaces; Magneto-encephalography (MEG); Neurolens Open Source Brain Imaging Software
3 In Vitro Diagnostics: In Vitro Diagnostics Regulatory Landscape; Genetic Testing and Pharmacogenomics; Protein Biomarker Assays; Pattern Recognition in Diagnostics
4 Neuroinformatics: Databases; Mind Research Network for Neurodiagnostic Discovery; Neuroinformatics Data Storage; Paul Allen Brain Atlas project; IBM Blue Brain Project; Diagnostic Software
5 Investing in Neurodiagnostics: Venture Capital Investment Trends; Neurodiagnostic Venture Financings, Companies and Investors 2005-2008; Public Investment Activity and IPO’s; Diagnostic Initial Public Offerings (IPOs), 2004 - 2008; Public Neurodiagnostic Related Companies, Stock Performance and Fundamentals; Merger and Acquisition Activity
6 Company Profiles: Neurodiagnostic Companies: Private; Neurodiagnostic Companies: Public

Abstract

Nearly 2 billion people worldwide and 100 million people in the US are affected by a brain or nervous system disorder including addiction, Alzheimer’s, depression, anxiety, schizophrenia, attention disorders, epilepsy, Parkinson’s disease, sensory disorders, and sleep disorders. Diagnosis of these disorders is rapidly changing as new tools are developed for more objective and personalized assessment and treatment.

In addition to the massive unmet markets, long term growth in neurodiagnostics is being driven by 1) technology advances and equipment upgrades in neuroimaging, 2) new biomarkers and imaging protocols for early diagnosis and disease monitoring, and 3) increased use of imaging and informatics in drug and device development.

Get Full Details About This Report >>

US: 800.298.5699

Int'l: +1.240.747.3093

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 300,000 market research reports, company profiles and country profiles from over 700 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.

2/14/2012 - 31

The Neurodiagnostics Report: Brain Imaging, Biomarkers and NeuroInformatics

Table of Contents

Abstract